Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / D••• B••• I•••

D••• B••• I•••

Stage unknownBoston, MAd•••.bioBiotechnology
Facts
Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Jun 13, 2025
    Form D equity offering · $11.0M (form d sold) · 12 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “D••• B••• I••• filed Form D: $10,999,976 sold (indefinite offering), Biotechnology”
  2. Oct 2, 2024
    Form D equity offering · $6.1M (form d sold) · 15 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “D••• B••• I••• filed Form D: $6,121,000 sold (indefinite offering), Biotechnology”
Investors on record
1 edges
People
2 officers, 0 directors
Timeline
2
  1. Jun 26, 2025
    D••• B••• I••• filed Form D: $10,999,976 sold (indefinite offering), Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Oct 17, 2024
    D••• B••• I••• filed Form D: $6,121,000 sold (indefinite offering), Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
32 observations
Every observation on this company